China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several experts ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

The five cities are Shanghai, Beijing, Guangzhou in Guangdong province, Tianjin, and Chongqing, with policies including instant tax refunds and visa-free transit.

China is accelerating the building of five major cities — Shanghai, Beijing, Guangzhou in Guangdong province, Tianjin and ...

China's retail sales, a significant indicator of consumption strength, grew 6.4 percent year-on-year in May, compared with a ...

Against an increasingly uncertain market backdrop, industry analysts EY said they are keeping an eye on potential ...

The decrease in retail spending was driven by a steep decline in car sales, just two months after consumers rushed to make ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

Ringo Choi, Asia Pacific IPO lasiaeader at EY, discusses Midea's secondary listing in Hong Kong and the opportunities in China's consumer sector. Russia launches a record number of drones into ...

Ernst & Young (EY) and KPMG have snapped up over half of PwC’s corporate clients in China that have fled the market’s leading accounting firm as it faces a regulatory probe, filings show.

EY AND KPMG GAIN. A Reuters calculation found EY had won at least 12 clients from PwC, including large state-backed financial institutions China Life, PICC and China Cinda Asset Management. The 12 ...